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α2-Macroglobulin (α2M) and haptoglobin (Hp) 
are both abundant secreted glycoproteins that 
are best known for their protease trapping and 
hemoglobin binding activities, respectively. 
Like the small heat shock proteins, both these 
glycoproteins have in common the ability to 
protect a range of proteins from stress-induced 
amorphous aggregation and have been 
described as extracellular chaperones. Using an 
array of biophysical techniques, this study 
establishes that in vitro, at substoichiometric 
levels and under physiological conditions, α2M 
and Hp both inhibit the formation of amyloid 
fibrils from a range of proteins. We also 
provide evidence that both α2M and Hp 
interact with prefibrillar species to maintain 
the solubility of amyloidogenic proteins. These 
findings suggest that both α2M and Hp are 
likely to play an important role in controlling 
the inappropriate aggregation of proteins in the 
extracellular environment. 
 
The pathology of more than 40 human 
degenerative diseases is associated with the 
deposition of proteinaceous fibrils or plaques 
commonly known as amyloid (1). These protein 
deposition diseases affect many of the tissues and 
organs of the human body and are comprised of 
various sporadic and occasionally familial 
amyloidogenic disorders, e.g. Alzheimer’s (AD) 
and Parkinson’s (PD) diseases, a number of 
transmissible prion-based disorders (e.g. 
Creutzfeldt-Jakob disease), and non-neuropathic 
disorders such as Type II diabetes and systemic 
lysozyme amyloidosis. Amyloid formation in vitro 
is now recognized as a common phenomenon and 
follows a kinetic pathway characteristic of 
crystallization; there is an initial ‘lag’ or 
nucleation phase, followed by a rapid exponential 
‘growth’ or polymerization phase (2), and finally a 
plateau phase in which no further fibril growth 
occurs. The lag phase is usually agreed to 
represent the time required for the formation of 
soluble (prefibrillar) oligomers or nuclei that are 
required to seed fibril growth.  
 
It has been proposed that proteins are able to 
aggregate and form amyloid deposits in vivo when 
the normally efficient protein quality control 
machinery is overwhelmed (3). As a consequence, 
a great deal of current research is focused on the 
protein quality control machinery and the role it 
plays in these disorders (4). However, in many 
cases, the disease-associated protein deposits are 
located in the extracellular environment outside 
the reach of the well-studied intracellular protein 
 2 
quality control machinery. Molecular chaperones 
are central components of the intracellular protein 
control system and it is only recently that the 
existence of extracellular counterparts to these 
species has been proposed (5). One such 
extracellular chaperone, clusterin, has been shown 
to potently inhibit amyloid formation when it is 
present during the early stages of the fibril-
forming process (6-9). Clusterin appears not to 
bind to the native form of the substrates tested, nor 
does it detectably bind to mature fibrils. 
Interestingly, binding to some species important 
for the nucleation event was observed to result in 
inhibition of fibril formation (8,9). Recently, two 
other secreted glycoproteins, haptoglobin (Hp) and 
α2-macroglobulin (α2M), have been shown to have 
chaperone activity similar to that of clusterin and 
to suppress the amorphous aggregation of a range 
of unrelated proteins (10,11). The role of these 
abundant extracellular chaperones in the formation 
of amyloid deposits in vivo is currently unknown 
but is of great interest in the context of 
understanding the triggers of amyloid diseases.  
 
α2M is an abundant human blood glycoprotein, 
comprised of ~10% carbohydrate by mass (12). It 
is best known for its ability to inhibit a broad 
range of proteases. Upon interaction with a 
protease, α2M undergoes limited proteolysis in a 
region containing a variety of protease cleavage 
sites (known as the bait region) leading to a major 
conformational change that results in the physical 
trapping of the protease within a steric “cage” 
(13). The trapped protease forms a covalent 
linkage with α2M by reacting with an 
intramolecular thiol ester bond to yield a 
conformationally altered form known as 
“activated” or “fast” α2M (α2M*). Activated α2M 
exposes a receptor recognition site for low density 
lipoprotein receptor related protein (LRP) (13). 
Small nucleophiles such as methylamine can also 
activate α2M by directly interacting with the thiol 
ester bond (14).  
 
Aside from its interactions with proteases, α2M 
binds to a wide range of ligands, including those 
associated with protein deposition disorders. 
Example of ligands include Aβ peptide (15), prion 
protein (16) and β2-microglobulin (17), which are 
strongly linked with Alzheimer’s disease, the 
spongiform encephalopathies and dialysis related 
amyloidosis, respectively. In addition, α2M binds 
to cytokines and growth factors (18), and to a 
range of hydrophobic structures including 
endotoxin, phenyl-Sepharose, and liposomes (19). 
Binding to hydrophobic molecules does not inhibit 
the trapping of proteases and is not known to be 
associated with any conformational changes (19). 
In accord with that discussed above, α2M is found 
associated with amyloid deposits in AD and 
spongiform encephalopathies (16,20). Previous 
work has indicated that α2M can inhibit the 
formation of amyloid fibrils by Aβ peptide (6) and 
protect cells from Aβ toxicity in an LRP 
dependent fashion (21). It was recently shown that 
α2M has a promiscuous ATP-independent 
chaperone action (11). It forms stable complexes 
with misfolded proteins and maintains their 
solubility but is unable to affect their refolding 
independently (11). Whether α2M can inhibit 
amyloid formation by peptides and proteins other 
than Aβ has not been tested. 
 
Hp is a secreted acidic glycoprotein produced 
mainly in the liver and found in most bodily fluids 
of humans and other mammals. The levels of Hp 
in human plasma are increased up to 8-fold during 
various physiological stresses (e.g. inflammation), 
leading to it being described as an "acute phase 
protein" (12,22). In humans, a cross-over event is 
thought to have produced two principal alleles 
(Hp1 and Hp2), which results in individuals 
expressing one of three major Hp phenotypes (Hp 
1-1, Hp 2-1, Hp 2-2). In its simplest form (Hp 1-
1), Hp exists in a disulfide-linked (α1β)2 structure 
with a molecular weight of ~100 kDa. However, in 
Hp 2-1 and Hp 2-2, an additional cysteine residue 
in the α2 chain allows the formation of a series of 
disulfide-linked αβ polymers (~100 to ~500 kDa). 
Hp is best known for its high affinity binding to 
hemoglobin (Hb) (KD ~ 10-15 M) (12). Formation 
of the Hp-Hb complex inhibits Hb-mediated 
generation of lipid peroxides and hydroxyl 
radicals, which are thought to occur in areas of 
inflammation (22). When complexed to Hb, Hp is 
known to be recognized by the cell surface 
receptors CD163 and Mac-1 and to be taken up by 
receptor-mediated endocytosis for degradation 
(23). Hp has also been implicated in immune 
regulation (24) and shown to inhibit cathepsin B 
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activity (25). Taken together, the available 
evidence indicates that Hp is likely to play an 
important role in suppressing the inflammatory 
response under a variety of different conditions.  
 
Human Hp specifically inhibits the precipitation of 
a wide variety of proteins induced by a range of 
stresses (10,26). Like clusterin, Hp forms stable 
and soluble high molecular weight complexes with 
misfolded proteins, but has no independent ability 
to refold misfolded proteins. Immunoaffinity 
depletion of Hp from human serum significantly 
increases the amount of protein that is precipitated 
in response to stresses (10). Thus, Hp has the 
ability to protect many different proteins from 
stress-induced amorphous precipitation and its 
effects in whole human serum suggest that this 
activity is likely to be relevant in vivo. Currently, 
there are no published studies of the effects of Hp 
on amyloid formation, although Hp is found 
associated with Aβ amyloid deposits in vivo (27). 
 
The aims of this study were to determine if α2M 
and Hp could affect the in vitro formation of 
amyloid aggregates by a range of unrelated 
proteins and, if so, to characterize the 
mechanism(s) involved. We selected three 
amyloid forming proteins that are linked to disease 
(Aβ1-42, calcitonin, and lysozyme which are 
associated with Alzheimer’s disease, a localized 
amyloidosis and a familial systemic amyloidosis, 
respectively) (1) and one other system, a designed 






α2M and Hp (phenotype 2-1) were purified from 
human plasma obtained from Wollongong 
Hospital (Wollongong, NSW, Australia) as 
previously described (10,11). The concentration of 
Hp was determined by absorbance at 280 nm using 
the molar extinction coefficient of 5.1 x 104 
(corresponding to a 50 kDa αβ dimer) (28). α2M 
concentrations were determined using an 
extinction coefficient of 8.93 for a 1% solution 
(corresponding to a 720 kDa tetramer) (19). 
Thioflavin T (Thio T), bicinchoninic acid (BCA) 
micro protein assay reagent, 
hexafluoroisopropanol (HFIP), and bovine serum 
albumin (BSA) were purchased from Sigma (MO, 
USA). Calcitonin (Calc) and the short coiled-coil 
β (ccβw) peptide, which transforms from a helical 
conformation at 20 oC into amyloid fibrils at 37 oC 
(9), were purchased from Auspep (Melbourne, 
Australia). Aβ1-42 was purchased from Biopeptide 
(San Diego, CA, USA), resuspended in HFIP and 
divided into aliquots in which the solvent was left 
to evaporate, resulting in a peptide ‘film’ that was 
frozen at - 80 oC. The non-natural variant of 
human lysozyme, I59T, was expressed and 
purified as described (29). The monoclonal anti-
Aβ antibody WO2 (hybridoma culture 
supernatant) was a kind gift from Dr Kevin 
Barnham (Department of Pathology, University of 
Melbourne, Australia). 
 
Fibril formation in vitro 
Immediately before use, Aβ1-42 was resuspended in 
buffer (2 parts 20 mM NaOH, diluted in 7 parts 
Milli Q water and 1 part 10X phosphate buffered 
saline (PBS; 137 mM NaCl, 2.7 mM KCl, 1.5 mM 
KH2PO4, and 8 mM Na2HPO4, pH 7.5)) and was 
centrifuged at 13,000 g for 10 minutes to remove 
any aggregated material. Aβ1-42 (10 µM) was 
shaken at 600 rpm for 8 h at 37 oC in PBS 
supplemented with 0.9 mM CaCl2, 0.5 mM MgCl2, 
100 µM CuCl2, and 600 µM glycine (PBSCu). 
ccβW (60 µM) and Calc (150 µM) were shaken at 
600 rpm for 300 min at 37 oC in 0.1 M Na2HPO4, 
pH 7.8, and 50 mM Na2HPO4, pH 7.4, 
respectively. Fibril formation by Aβ, ccβw and 
Calc, in the presence or absence of either Hp or 
α2M, was measured in situ by Thio T fluorescence 
(see below) using a FLUOstar OPTIMA 
fluorescence plate reader (BMG Labtech, 
Australia). Variant human lysozyme (I59T) (6.8 
µM in 0.1 M sodium citrate buffer, pH 5.0) was 
incubated at 60 °C in a stirred 1 ml cuvette, and 
light-scattering monitored at 500 nm (5 nm slit 
width) using a Cary Eclipse spectrofluorimeter 
(Varian Ltd., Oxford UK); the stirred cuvette was 
found to give more reproducible I59T aggregation 
than incubation in multiwell plates. Furthermore, 
co-incubation of Thio T with protein mixtures 
containing I59T was found to affect the rate of 
protein aggregation, thus Thio T analyses were 
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performed only at the endpoint of each assay (see 
below). Molar concentrations were calculated 
using the monomeric molecular masses of the 
amyloid forming peptides, and masses of 720 kDa 
for the α2M tetramer and 50 kDa for Hp (based on 
the αβ dimer). To confirm that Hp and α2M do not 
themselves form Thio T reactive aggregates under 
the conditions used, each protein (at 1.0-12.5 µM) 
was treated as described above and the Thio T 
fluorescence then measured.  
 
Effects of hemoglobin binding on the ability of 
Hp to inhibit amyloid formation 
To generate Hp–hemoglobin (Hb) complexes (Hp-
Hb), Hp (15 µM) was incubated with Hb in PBS in 
an equimolar ratio for 2 h at room temperature. To 
form amyloid, 10 µM Aβ1-42 was shaken at 600 
rpm for 8 h at 37 oC in PBSCu; 60 µM ccβW was 
shaken at 600 rpm for 300 min at 37 oC in PBS. 
Fibril formation in the presence or absence of 
either Hp or Hp-Hb, was measured as in situ Thio 
T fluorescence (see below) using a FLUOstar 
OPTIMA fluorescence plate reader (BMG 
Labtech, Australia). Molar ratios of 1:20 Hp:Aβ 
and 1:30 Hp:ccβw were used as these ratios did not 
completely prevent aggregation and any effects, 
positive or negative, on chaperone action could be 
determined. To confirm that Hb alone did not 
affect the formation of Thio T reactive aggregates 
under the conditions used, Hb alone at the same 
final concentration was added to reactions as 
described above and the Thio T fluorescence then 
measured.  
 
Thioflavin T fluorescence assays 
Thio T (50 µM) was added to aggregation 
mixtures of Aβ1-42, ccβW, or Calc and the 
fluorescence measured at intervals using a 
FLUOstar OPTIMA fluorescence plate reader with 
440 nm excitation (10 nm slit-width) and 490 nm 
emission (10 nm slit width). In the case of I59T, 
only the endpoint Thio T fluorescence was 
measured using a Cary Eclipse spectrofluorimeter 
with 440 nm excitation (slit-width 10 nm) and an 
emission scan from 450–600 nm (slit-width 10 
nm).  
 
Effects of α2M and Hp on mature amyloid 
fibrils 
Amyloid fibrils were formed using conditions 
outlined above. At the conclusion of in vitro fibril 
formation time courses, α2M or Hp were added to 
give molar ratios of α2M/Hp:Aβ = 1:10, 
α2M/Hp:Calc = 1:15, and α2M/Hp:ccβw = 1:15, 
and incubated for a period of 500 min at 37oC. The 
samples were subsequently analysed using Thio T 
fluorescence (as described above) and then 
centrifuged for 30 min at 10,000 g. The 
supernatant was removed and the pellet 
resuspended and washed repeatedly in PBS. 
Insoluble material was then redissolved in DMSO 
before being diluted 10 fold in PBS. A BCA micro 
protein assay was conducted (as per the 
manufacturer's instructions) to quantify the protein 
content of the resulting samples.  
 
Transmission electron microscopy (TEM) 
Endpoint samples of aggregation reactions 
incubated as outlined above, in the presence or 
absence of α2M or Hp (at molar ratios of 
α2M/Hp:Aβ/I59T = 1:10  or α2M/Hp:ccβw/Calc = 
1:15), were applied to Formvar and carbon-coated 
nickel electron microscopy grids and stained with 
uranyl acetate (2% (w/v), Agar Scientific, UK). A 
Philips CM100 transmission electron microscope 
(FEI Company, USA) was used to view samples 
under a magnification of 20-125 K at an 80 kV 
excitation voltage. Images were analyzed using the 
SIS Megaview II Image Capture system 
(Olympus, Germany). 
 
Effects of α2M and Hp on the sedimentation 
properties of substrate proteins 
 
At the endpoints of the aggregation reactions, 
samples of Aβ , Calc and I59T, with or without 
α2M or Hp, were centrifuged for 30 min at 10,000 
g. The supernatant was removed and the pellet 
resuspended and subsequently washed repeatedly 
in PBS. Aβ samples were analyzed by 15% SDS 
PAGE and subsequent immunoblotting using 
WO2 (an anti-Aβ  monoclonal antibody). 
Electrophoretic blotting of Calc was not performed 
because its low molecular mass (3418 kDa) results 
in a very low efficiency of transfer to the 
membrane. Instead, Calc samples were analyzed 
by spotting them directly onto a nitrocellulose 
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membrane (Pall, FL, USA) before blocking with 
HDC/PBS and probing with a rabbit anti-Calc 
antibody (Abcam, Sydney, Australia).  I59T 
samples were analyzed by 10% SDS PAGE and 
subsequent immunoblotting using a polyclonal 
rabbit anti-lysozyme antibody (Washington 
Biotechnology, Simpsonville, MD, USA). Bound 
antibodies were detected with either HRP-
conjugated sheep anti-mouse IgG or sheep anti-
rabbit IgG antibodies (Silenus, Melbourne, 
Australia) followed by enhanced 
chemiluminescence (ECL) with Supersignal West 
Pico Chemiluminescent Substrate (Pierce, IL, 
USA).  
 
 Immuno dot blots 
Samples of Aβ (1 µg) , taken at various time 
points during fibril formation and stored frozen at 
- 20 oC were spotted on to nitrocellulose 
membranes (Pall, FL, USA) and allowed to air 
dry. The membranes were then blocked with 1% 
(w/v) heat denatured casein in PBS (HDC/PBS) 
and incubated for 2 h at 37 oC in PBS containing 
10 µg/ml α2M or Hp, or control protein GST, 
before being washed with PBS. Bound α2M and 
Hp were detected using specific rabbit polyclonal 
antibodies (Sigma and DAKO, respectively). A 
rabbit anti-GST antibody (Chemicon, Melbourne, 
Australia) was used to detect any bound control 
protein. Bound primary antibodies were detected 




To determine if stable complexes are formed 
between α2M or Hp and amyloid-forming 
peptides, we sampled aggregation reactions 
containing sufficient α2M or Hp to inhibit most of 
the protein aggregation that is observed in their 
absence (i.e. molar ratios of α2M/Hp:Aβ/I59T = 
1:10, α2M/Hp:Calc = 1:15). These samples 
contained almost all the substrate protein in the 
soluble fraction (see immunoblot analyses of 
corresponding samples in Figure 4A-C) and were 
centrifuged at 13,000 g for 10 min before analysis 
to remove any traces of insoluble materials. 
Samples were taken at a time corresponding to the 
mid-point of the aggregation process in the 
absence of the chaperones, and were subsequently 
analyzed by a sandwich ELISA. Aggregation 
reactions were initiated as above using molar 
ratios of α2M/Hp to substrate of 1:10 (Aβ and 
I59T) or 1:15 (Calc and ccβw). In the cases of Aβ 
and ccβw, the peptides were biotinylated using 
standard methods prior to the aggregation reaction. 
This modification did not affect the ability of the 
peptides to form thio T positive aggregates (data 
not shown). 96 well plates (Greiner Bio-one, 
Sydney, Australia) were coated with 10 µg/ml of 
either anti-α2M (Dako, Glostrup, Denmark) or 
anti-Hp (Sigma, Sydney, Australia) antibodies 
raised in rabbit and then blocked with 1% (w/v) 
BSA in PBS. Samples of aggregation mixtures 
(with or without α2M or Hp), were next added to 
the wells at a concentration of 50 µg/ml of 
amyloid forming protein. In other wells, solutions 
of α2M or Hp alone (at the same final 
concentrations as in the corresponding mixtures) 
were added. Next, a mixture of streptavidin and 
biotinylated-HRP (each at 2.5 µg/ml in 1% (w/v) 
heat-denatured casein in PBS) was used to detect 
bound Aβ or ccβw. Antibody detection of bound 
Calc was performed as described above. Bound 
I59T was detected using a mouse monoclonal anti-
lysozyme antibody (Serotec, UK), followed by 
HRP-conjugated sheep anti-mouse IgG. Finally, 
plates were washed 3 times in PBS containing 0.1 
% (v/v) Triton X-100 and then in PBS alone 
before being developed using 2.5 mg/ml o-
phenylenediamine dihydrochloride and 0.03% 
(w/v) H2O2 in 0.05 M citric acid, 0.1M NaHPO4 
(pH 5) as substrate. The absorbance was measured 
at 490 nm in a SpectraMax Plus 384 microplate 
reader (Molecular Devices, USA). Negative 
controls included the use of an antibody that has 
no specificity to the proteins under investigation 
(rabbit anti-DNP), and wells incubated with only 
the mixture of streptavidin and biotinylated HRP 





α2M and Hp inhibit fibril formation in vitro 
In the absence of α2M and Hp, aggregation of all 
the substrates tested showed a lag phase followed 
by a rapid growth phase, which eventually 
approached a plateau. The lag phases were 
somewhat variable between individual 
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experiments but ranged from approximately 25-50, 
5-20, 20-30 and 75-150 min for Aβ, ccβw, Calc 
and I59T, respectively (see Figures 1A-D & 2A-
D). The addition of α2M to all fibril-forming 
reactions produced a dose-dependent decrease in 
Thio T positive aggregation in each case (Figure 
1). In the case of I59T, for which aggregation was 
followed by measuring absorbance at 500 nm, 
analysis of endpoint samples confirmed that Thio 
T fluorescence was reproducibly suppressed by 
α2M (Figure 1E; α2M:I59T = 1:10). α2M extended 
the lag phase in all reactions even though the final 
level of aggregation was not always greatly 
reduced (Figure 2A-D); this observation suggests 
that α2M affects the nucleation step in the 
aggregation reaction. A sub-stoichiometric ratio of 
α2M:substrate was sufficient to inhibit aggregation 
almost completely in each case (1:10 for Aβ and 
I59T; 1:15 for ccβw and Calc). Hp also inhibited 
the aggregation of all substrates tested in a dose-
dependent manner (Figure 2). Like α2M, at 
concentrations where aggregation was not 
completely suppressed, Hp extended the lag phase 
significantly (Figure 2A-D). As with α2M, a sub-
stoichiometric ratio of Hp:substrate was sufficient 
to inhibit almost completely all the Thio T positive 
aggregation (1:10 for Aβ and I59T, 1:15 for ccβw 
and Calc). In the case of I59T, endpoint Thio T 
analysis confirmed that Hp substantially 
suppressed Thio T fluorescence (Figure 2E; 
Hp:I59T = 1:10). The presence of the control 
protein BSA in the amyloid forming reactions had 
no effect on aggregation for any of the substrates 
tested (supplemental Fig. S1). In addition, when 
incubated alone, neither Hp nor α2M generated 
Thio T-reactive material under any of the 
conditions tested (data not shown). When 
complexed with hemoglobin, Hp retained the 
ability to inhibit amyloid formation by Aβ and 
ccβw, however this ability was less than that of 
uncomplexed Hp (supplemental Fig. S2).  
 
To verify that both α2M and Hp can inhibit the 
formation of amyloid fibrils we examined protein 
aggregation mixtures with and without α2M and 
Hp using transmission electron microscopy 
(TEM). In the absence of either α2M or Hp, 
samples from all substrate proteins tested 
contained fibrillar aggregates (Figure 3). Addition 
of α2M to the Calc and I59T aggregation reactions 
substantially inhibited the formation of fibrils, and 
only a small number of short fibril-like structures 
were observed in 1:10 α2M:Aβ and 1:15 α2M:ccβw 
samples (Figure 3). The addition of Hp to Aβ, 
ccβw and I59T aggregation reactions (at ratios of 
Hp:substrate of 1:10, 1:15 & 1:10, respectively) 
significantly inhibited the formation of fibrils; 
only small amounts of amorphous material were 
detected in these samples (Figure 3). However, 
although a 1:15 ratio of Hp:Calc substantially 
reduced Thio T fluorescence (Figure 2C), a variety 




Both α2M and Hp affect the sedimentation 
properties of amyloid forming proteins 
 
α2M and Hp were added at various concentrations 
to Aβ, Calc and I59T fibril formation reactions 
and at the end of the time course the samples were 
centrifuged to obtain supernatant and pellet 
fractions. The Aβ and I59T samples were then 
analyzed by immunoblotting. Due to the low 
efficiency with which relatively small peptides are 
electrophoretically transferred to nitrocellulose, 
Calc samples were analyzed by immuno dot 
blotting. ccβw samples could not be analysed in 
either of these ways because there are no suitable 
commercially available antibodies; furthermore, it 
stains very poorly with Coomassie blue making 
SDS PAGE analysis difficult. In the absence of 
α2M or Hp, Aβ was found exclusively in the pellet 
fraction and consisted of high molecular mass 
aggregates (Figure 4A; Aβ alone). When α2M was 
added to the reaction to give a 1:10 molar ratio of 
α2M:Aβ, all of the Aβ was found in the 
supernatant fraction; subsequent decreases in the 
amount of α2M added to the reaction resulted in a 
progressive shift of Aβ from the supernatant 
fraction to the pellet fraction (Figure 4Ai). 
Similarly, the addition of a 1:10 molar ratio of 
Hp:Aβ resulted in the presence of Aβ in the 
supernatant fraction; as the amount of Hp added 
was decreased, progressively more Aβ  was found 
in the pellet fraction (Figure 4Aii). In the absence 
of either α2M or Hp, Calc was detected only in the 
pellet fraction (Figure 4B). In contrast, when α2M 
was present in the reaction (at α2M:Calc = 1:15), 
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most of the Calc was detected in the supernatant 
fraction and the proportion of Calc in the pellet 
fraction increased as the amount of α2M in the 
reaction decreased (Figure 4B). Similarly, in the 
presence of Hp (Hp:Calc = 1:15) all of the Calc 
was detected in the supernatant fraction and 
subsequent decreases in Hp resulted in more Calc 
detected in the pellet fraction (Figure 4B). In the 
absence of either α2M or Hp, I59T was detected 
only in the pellet fraction (Figure 4C). In contrast, 
when incubated in the presence of either α2M or 
Hp (α2M/Hp:I59T = 1:10), I59T was detected 
primarily in the supernatant fraction (Figure 4C).  
 
α2M and Hp do not influence fibril elongation or 
disrupt pre-formed fibrils  
To determine whether α2M and Hp inhibit fibril 
formation by affecting the nucleation and/or fibril 
elongation phases, α2M or Hp was added either at 
the beginning of the reaction (0 min) or mid-way 
through the elongation phase of aggregating Aβ, 
ccβw, calc or I59T (at 150, 50, 75 and 100 min, 
respectively). Addition of either α2M or Hp at zero 
time (Hp/α2M:substrate = 1:10) resulted in almost 
total inhibition of aggregation over the entire 
reaction (Figure 5). In contrast, when the same 
molar ratios of α2M or Hp were added to the 
reactions during the elongation phase, there were 
little or no measurable effects on aggregation 
(Figure 5A and 5B). It was also shown that, over a 
500 min time frame, the addition of α2M or Hp to 
pre-formed fibrils of Aβ, Calc or ccβw had no 
measurable effect on the integrity of the fibrils 
(supplemental Fig. S3). 
 
α2M and Hp bind transient prefibrillar species 
on the Aβ  amyloid formation pathway  
 
Samples taken at various points in time during Aβ 
fibril formation reactions in the absence of Hp and 
α2M were spotted on to nitrocellulose membranes. 
Maximum binding of both α2M and Hp was 
detected to Aβ species present in samples taken 
0.5 and 1 hour after the initiation of aggregation 
(Figure 6). These times correspond to the 
transition between the lag and growth phases 
(Figure 6). α2M and Hp were not found to bind to 
the native substrates present in samples at the zero 
timepoint, nor to the final timepoint samples 
(Figure 6). There was also no detectable binding of 
the control protein GST to any of the Aβ samples 
tested (data not shown). In addition when assayed 
by immuno dot blotting there was no detectable 
binding of α2M or Hp to species present at any 
time in the aggregation reactions of any of the 
other substrates tested (data not shown). The 
reasons for this observation are unclear but might 
result from the interacting species being present at 
levels too low to detect using this assay procedure. 
We therefore used a sandwich ELISA method to 
demonstrate the formation of α2M/Hp-substrate 
protein complexes in the aggregation reactions. 
 
 
α2M and Hp form stable complexes with species 
on the amyloid forming pathway 
 
A sandwich ELISA was used to determine whether 
or not α2M and Hp form stable complexes with 
substrate proteins during aggregation reactions. 
We observed a statistically significant increase in 
absorbance (p < 0.05) when aggregation mixtures 
of α2M and Aβ, ccβw or calc were compared with 
samples containing substrate alone and with 
negative controls (Figure 7A). We were unable to 
detect a corresponding increase in absorbance for 
samples taken from mixtures of α2M and I59T 
(Figure 7A), Samples from aggregation mixtures 
containing Hp and any of the four substrate 
proteins we studied also gave significantly higher 
absorbances than corresponding samples of 
aggregation reactions containing substrate alone, 




Previous work has indicated that α2M can inhibit 
the in vitro formation of amyloid fibrils by Aβ (6). 
In addition, both α2M and Hp have been found 
associated with Aβ plaques in Alzheimer’s 
patients (20,27). The results presented here 
demonstrate that both α2M and Hp can potently 
inhibit the in vitro formation of amyloid fibrils by 
a diverse panel of proteins under physiologically 
relevant conditions. For Aβ, ccβw and Calc these 
effects were observed at 37 oC and pH 7.5. In the 
case of Aβ, fibril formation was induced by the 
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addition of 100 µM Cu2+ (30), the concentration 
that Cu2+ can reach in the normal human neocortex 
(31); in the neuropil of the cortical and accessory 
basal nuclei of the amygdala of Alzheimer 
diseased brains it has been reported to reach 
several times this level (32). Hp and α2M both 
exert similar activity under the non-physiological 
conditions used here to form fibrils from I59T (60 
oC, pH 5). We have previously shown that both 
α2M and Hp remain fully functionally active at 
this elevated temperature and do not aggregate 
even when incubated at 60 oC for extended periods 
(10,11). These data suggest that the anti-
amyloidogenic activities of Hp and α2M are not 
dependent on the identity of the polypeptide 
substrate or the conditions under which it is 
incubated. This activity was found to be specific 
since similar levels of the control protein BSA 
(molar ratio of BSA:substrate = 1:10) had no 
detectable effect on the aggregation of any of the 
substrates tested here (supplemental Fig. S1). Hp 
retained the ability to inhibit amyloid formation 
even when complexed with hemoglobin, although 
this activity was reduced when compared to that of 
uncomplexed Hp. This is consistent with a 
previous report that complexation with Hb reduces 
but does not abolish the ability of Hp to inhibit the 
amorphous aggregation of protein (33). We have 
previously reported that activation of α2M by 
interaction with trypsin abolished its ability to 
inhibit the amorphous heat-induced aggregation of 
two globular proteins (11). The effects of protease 
activation on the ability of α2M to inhibit amyloid 
formation are complex and are influenced by the 
facts that the bound protease remains catalytically 
active and sterically accessible to small protein 
substrates of less than 8 kDa in mass (but not to 
those of greater mass) (34). The consequences of 
this for the anti-amyloidogenic activity of α2M 
will be dealt with in detail in a separate report. 
  
In all cases examined in this study, significantly 
sub-stoichiometric molar ratios of α2M or Hp to 
substrate (from 1:10 to 1:15) were enough to 
substantially inhibit the formation of amyloid 
fibrils as judged by thioflavin T fluorescence, light 
scattering and TEM (Figures 1-3). When present at 
sufficient levels, both α2M and Hp reduced the 
sedimentability of species present in aggregation 
reactions of Aβ, Calc and I59T (Figure 4). In some 
experiments, lower levels of α2M and Hp 
(Hp/α2M:substrate of 1:500 to 1:30, Figures 1 & 
2), failed to reduce the final level of protein 
aggregation. However, in these cases the lag phase 
of the reaction was significantly extended. This 
suggests that when present at low levels, the 
effects of α2M and Hp are eventually 
overwhelmed, but that even under these conditions 
they can delay nucleation and thus defer the 
subsequent elongation phase. Both α2M and Hp 
were more effective at suppressing aggregation of 
amyloidogenic substrates when added at the 
initiation of the reaction rather than when added 
during the elongation phase (Figure 5). This 
finding suggests that both proteins exert their 
effects on amyloid formation primarily by 
interacting with species on the amyloid-forming 
pathway that are more abundant prior to fibril 
elongation. Together with the observation that 
both α2M and Hp effectively extend the lag phase 
even when present at low concentrations, these 
data suggest that they interact with protein species 
that are either functional nuclei or their precursors. 
Immuno dot blot analyses show α2M and Hp bind 
to transient species of Aβ present early in the 
aggregation time course (Figure 6). α2M and Hp 
appear not to bind to samples taken before the start 
of the reaction or those taken at the end of the 
reaction (Figure 6). This result demonstrates that, 
at least in the case of Aβ, α2M and Hp do not 
detectably bind to the native monomer or to 
mature fibrils formed from them. It was also 
shown that, at least over a 500 min co-incubation, 
α2M and Hp did not affect the stability of mature 
fibrils formed from Aβ, Calc or ccβw 
(supplemental Fig. S3). These data are all 
consistent with the idea that both α2M and Hp 
specifically bind to species that are particularly 
abundant during fibril nucleation.  
 
The above suggests that α2M and Hp form 
complexes with conformations of substrate 
proteins which are intermediate on the amyloid 
forming pathway; these complexes could be either 
short lived or more persistent. Analysis of 
aggregation mixtures by sandwich ELISA strongly 
suggest that stable complexes are formed between 
Hp and all four substrate proteins tested. The fact 
that complexes between α2M and I59T were not 
detected suggests that the interacting species are 
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present in this case at very low levels. 
Nevertheless, it seems likely that α2M binds to 
aggregation-prone prefibrillar species formed early 
in aggregation reactions.  
 
Collectively, the results indicate that sub-
stoichiometric levels of α2M and Hp effectively 
suppress amyloid fibril formation in vitro by a 
broad range of protein substrates. The data suggest 
that both α2M and Hp exert this activity by 
interacting with one or more transient species on 
the amyloid forming pathway that is populated 
most heavily before fibril elongation begins. This 
conclusion is consistent with the hypothesis that 
like clusterin, α2M and Hp bind to species sharing 
common structural features present during 
amyloid formation of a range of substrates (9). 
The interactions between α2M/Hp and substrate 
proteins appear to be stable and act to preserve the 
solubility of the substrates. The current findings 
are in accord with previous work demonstrating 
that both α2M and Hp have chaperone activity 
similar to that of the small heat shock proteins. 
Both α2M and Hp inhibit the formation of 
amorphous aggregation by a range of proteins by 
forming soluble complexes (10,11). Together with 
previous findings (8-11,35), the work presented 
here suggests that clusterin, α2M and Hp make up 
a small family of extracellular chaperones that 
may be an important part of an in vivo quality 
control system for extracellular proteins. It has 
been proposed that extracellular chaperones 
respond to misfolded or aggregating proteins in 
extracellular space by binding to exposed 
hydrophobic regions, maintaining the solubility of 
the substrate and promoting its removal from the 
extracellular space via receptor mediated 
endocytosis. This proposal is fully consistent with 
all the data presented here, and with data that show 
that the removal of radiolabelled Aβ from mouse 
brain is significantly inhibited by the LDL family 
inhibitor RAP and antibodies against the α2M 
receptor (LRP-1) and α2M (36). This hypothesis is 
also supported by the demonstration that, when 
complexed with clusterin, the rate of clearance of 
Aβ1-42 from the mouse brain (across the blood 
brain barrier into plasma) is increased by more 
than 80% and that this transport is significantly 
inhibited by anti-megalin antibodies (37).  
 
Clusterin (8,9), and both α2M and Hp (this study), 
appear to inhibit amyloid formation and maintain 
substrate protein solubility by interacting with 
prefibrillar species. These extracellular chaperones 
are also known to potently inhibit amorphous 
aggregation of proteins (10,11,35,38,39). We 
suggest that this small family of chaperones is 
likely to be an important part of a system that 
defends the human body against inappropriate 
extracellular protein aggregation, which can be 
either amorphous or amyloid in character. 
Presumably, it is only during exceptional 
circumstances (e.g. the result of a mutation, age-
related loss-of-function, or acute stress) that this 
system of defence is overwhelmed and disease 
results. The increasing number of known 
extracellular deposition disorders, which include 
conditions such as Alzheimer’s disease and Type 
II diabetes, has made the need for understanding 
the mechanisms controlling extracellular protein 
folding of major importance to modern health 
care. Greater understanding of these processes will 
ultimately lead to the development of new 
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Figure 1 α2M suppresses the aggregation of amyloidogenic proteins. Samples of Aβ (10 µM), ccβw 
(60 µM), Calc (50 µM), and I59T (6.8 µM) were incubated as described in Experimental Procedures, 
and amyloid formation monitored by in situ measurements of Thio T fluorescence (A-C), or for I59T by 
measuring turbidity (absorbance at 500 nm; D) and endpoint measurement of Thio T fluorescence 
emission spectra (E). In A-E, the open circles represent data for the proteins aggregating in the absence 
of α2M; the molar ratio of α2M to substrate protein is indicated next to the variously shaded circles on 
each panel. In (E), the spectrum of Thio T alone (in the absence of any protein) is also shown. The data 
points shown are representative of at least three 3 independent experiments.  
 
Figure 2 Hp suppresses the aggregation of amyloidogenic proteins. The experiments with Aβ (10 
µM), ccβw (60 µM), Calc (50 µM), and I59T (6.8 µM) are analogous to those described for α2M in the 
legend for Figure 1. 
 
Figure 3 α2M and Hp suppress the formation of fibrillar structures. TEM images of samples taken at 
the conclusion of aggregation reactions containing substrate proteins either alone or in the presence of 
α2M or Hp (as indicated above the panels). The molar ratio of Hp/α2M:substrate used was 1:10 for 
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Aβ and Ι59Τ, and 1:15 for ccβw and Calc. In all cases the results shown are representative of two or 
more individual experiments. The scale bar in the lower right panel applies to all TEM images shown 
here and represents 500 nm. 
 
Figure 4 α2M and Hp form stable complexes with Aβ and maintain its solubility. (A) Aβ immunoblot 
showing supernatant (S) and pellet (P) fractions prepared by centrifugation of aggregation reactions 
containing various ratios of α2M/Hp:Aβ (indicated above the corresponding lanes). (B) Images of 
immuno dot blots showing supernatant (S) and pellet (P) fractions resulting from centrifugation of 
samples from aggregation reactions containing various ratios of α2M/Hp:Calc (indicated above the 
corresponding spots). (C) I59T immunoblot showing supernatant (S) and pellet (P) fractions prepared 
by centrifugation of samples from aggregation reactions containing I59T alone or a 1:10 ratio of 
α2M/Hp:I59T (indicated above the corresponding lanes). The results shown are representative of at least 
2 independent experiments.  
 
Figure 5 α2M and Hp are most effective when added at the start of the aggregation reaction.  
Samples of Aβ (10 µM), ccβw (60 µM), Calc (50 µM) and I59T (6.8 µM) were incubated as described 
in Experimental Procedures and amyloid formation was monitored by in situ measurements of Thio T 
fluorescence (i-iii), or for I59T by measuring turbidity (iv).  1:10 ratios of (A) α2M:substrate or (B) 
Hp:substrate were added at either time zero (grey diamonds) or at the mid-point of the elongation phase 
(grey circles; addition of α2M and Hp indicated by arrows). Each symbol represents an individual 
measurement and the results shown are representative of at least 2 independent experiments.  
 
Figure 6 α2M and Hp bind transient species early in Aβ  fibril formation. Results of immuno dot blot 
assay measuring the binding of α2M and Hp to protein species present at different times during Aβ 
fibril formation. Aβ (10 µM) was incubated as described in Experimental Procedures and aliquots taken 
at various time points. The times at which individual samples were taken are indicated above the 
images and the Thio T fluorescence of each aliquot was measured. Aβ (∼ 1 µg) from each sample was 
then spotted onto nitrocellulose and the membrane blocked and subsequently incubated with 10 µg/ml 
of either α2M or Hp. The presence of α2M and Hp was detected using rabbit anti-α2M and anti-Hp 
antibodies.  
 
Figure 7  α2M and Hp form stable complexes with amyloid forming proteins. Histograms showing the 
results of sandwich ELISA detecting complexes formed between α2M/Hp and amyloid forming 
proteins. Samples taken from aggregation reactions at times corresponding to the midpoint of the 
elongation phase (in the absence of α2M/Hp) were analyzed by ELISA using plate bound anti-α2M (A) 
or anti-Hp (B) antibodies to capture α2M and Hp respectively. Bound amyloid forming proteins were 
subsequently detected using specific antibodies, or (in the case of biotinylated Aβ and ccβw) a 
streptavidin/biotinylated-horseradish (b-HRP) peroxidase complex. Non-specific binding of substrate 
was tested using samples taken from aggregation reactions of substrate alone at the same time points. 
For biotinylated Aβ and ccβw, the negative controls were anti-α2M/anti-Hp coated wells incubated with 
only streptavidin/biotinylated-horseradish peroxidase complex. For Calc and I59T, the negative controls 
were provided by substituting appropriate antibodies of irrelevant specificity for the anti-Calc or anti-
lysozyme antibodies (see Experimental Procedures for details). Values shown represent the mean of at 
least 3 wells and error bars represent standard error. Significant differences to controls are indicated by 
* (Student’s t-test; p < 0.05). Results shown are representative of at least 2 independent experiments. 
 




Supplementary Figure S1 Control protein BSA does not inhibit aggregation of amyloid forming proteins. Aβ 
(10 µM), ccβw (60 µM), Calc (50 µM), and I59T (6.8 µM) were incubated as described in Experimental 
Procedures and amyloid formation monitored by in situ measurements of Thio T fluorescence (A-C), or for I59T 
by measuring turbidity (absorbance at 500 nm; D). In A-E, the empty circles represent data for the protein 
aggregating in the absence of BSA; when present, the molar ratio of BSA to substrate protein is 1:10. Data points 
shown are individual measurements and are representative of at least three 3 independent experiments.  
 
 
Supplemental Figure S2 Haptoglobin suppression of amyloid forming protein aggregation is affected 
by binding of Hb. Aβ (10 µM) and ccβw (60 µM) were incubated as described in Experimental 
Procedures and amyloid formation monitored by in situ measurements of Thio T fluorescence. The 
empty circles represent data for the protein aggregating in the absence of Hp, while shaded symbols 
represent amyloid forming protein incubated with Hp or a preincubated equimolar mixture of Hp and 
Hb (as indicated on panels). In all cases when present, the molar ratio of Hp to Aβ and ccβw is 1:10 and 
1:15, respectively. Data points shown are individual measurements and are representative of at least 
three 3 independent experiments.  
 
Supplemental Figure S3 α2M and Hp do not dissociate mature amyloid fibrils. (A) Histogram showing 
the end point Thio T fluorescence of mature fibrils incubated with either α2M or Hp (as described in 
Experimental Procedures) for 500 minutes at 37oC in PBS. (B) Protein content of insoluble material 
retrieved by centrifugation at the endpoint of mixtures containing mature fibrils and either α2M or Hp 
(molar ratios as above). Values shown represent the mean of at least 3 determinations and error bars 
represent standard error. Results shown are representative of at least 2 independent experiments. 
 










